ArticleJournal of ovarian research2020

Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report.

Yu-Chien Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.